Status:
COMPLETED
Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Conditions:
Breast Neoplasm Female
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Many doctors believe that breast cancer patients scheduled for pre-operative chemotherapy whose cancer has spread to the axilla (determined by palpation plus ultrasound) should not receive sentinel no...
Eligibility Criteria
Inclusion
- cT2 cN0/1 breast cancer
- Scheduled for neoadjuvant chemotherapy,
- Informed consent,
Exclusion
- Previous malignancy at another site
- Synchronous breast cancer at diagnosis
- Distant metastasis at diagnosis
- Clinically involved axilla (cN1) after neoadjuvant chemotherapy
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2015
Estimated Enrollment :
353 Patients enrolled
Trial Details
Trial ID
NCT04436809
Start Date
January 1 2007
End Date
December 31 2015
Last Update
June 22 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.